2017
DOI: 10.1080/20018525.2016.1274099
|View full text |Cite
|
Sign up to set email alerts
|

Introduction of cryobiopsies in the diagnostics of interstitial lung diseases – experiences in a referral center

Abstract: Introduction: Transbronchial cryobiopsies (cTBB) has emerged as a new method for obtaining lung tissue biopsies in the diagnosis of interstitial lung diseases (ILDs). Until now, it has been used in a few highly specialized interventional centers and has shown promising results in obtaining a definite diagnosis of ILDs. Method: All patients undergoing a cTBB between November 2015 and June 2016 were included in this case series study. Data on patient demographics, high-resolution computed tomography patterns, si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
42
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(52 citation statements)
references
References 20 publications
8
42
2
Order By: Relevance
“…In an in vivo animal study of large airway mucosal biopsy using both cryoprobes, mean biopsy diameter was only slightly larger using the 2.4 mm probe after 1, 2, and 3 second freeze times and biopsy weight was not significantly different after 3 second freezes (60); how well this reflects cryoprobe behavior in the peripheral lung is not clear. Neither probe size is predominant in published cases to date and some series report using both probes in an interchangeable fashion (5,44,45,47). Likewise, both carbon dioxide and nitrous oxide have seen wide use as the cryogen gas for cryobiopsy.…”
Section: Cryoprobe Size Cryogen and Activation-freeze Timementioning
confidence: 99%
See 1 more Smart Citation
“…In an in vivo animal study of large airway mucosal biopsy using both cryoprobes, mean biopsy diameter was only slightly larger using the 2.4 mm probe after 1, 2, and 3 second freeze times and biopsy weight was not significantly different after 3 second freezes (60); how well this reflects cryoprobe behavior in the peripheral lung is not clear. Neither probe size is predominant in published cases to date and some series report using both probes in an interchangeable fashion (5,44,45,47). Likewise, both carbon dioxide and nitrous oxide have seen wide use as the cryogen gas for cryobiopsy.…”
Section: Cryoprobe Size Cryogen and Activation-freeze Timementioning
confidence: 99%
“…Two series have piloted the use of two bronchoscopes to allow more rapid re-entry into the airway after each biopsy in lieu of endobronchial blocker use, with low rate of serious hemorrhage reported (44,46). Kronborg-White et al, administered intravenous tranexamic acid at the start of all cryobiopsy procedures, with moderate bleeding in 16% of cases, some of whom received additional tranexamic acid (47). Finally, a smaller 1.1 mm cryoprobe used in conjunction with an oversheath is in development.…”
Section: Bleeding Preparedness and Managementmentioning
confidence: 99%
“…Some studies define DY by histopathologic diagnosis alone while others report on DY by MDD diagnoses. 2,3,5,7,26,28,[31][32][33][34][35][36][37][38][39][40][41][42][43] Current guidelines recommend a MDD by expert pulmonologists, radiologists, and pathologists to reach a consensus clinical diagnosis based on the review of the clinical, radiologic, and pathologic data. 13,22,44,45 In the largest case series published to date which included 297 cases, Ravaglia et al reported a DY of 82.8% when TBLCB was utilized as a part of the MDD.…”
Section: Diagnostic Yieldmentioning
confidence: 99%
“…Transbronchial lung cryobiopsy (TBLC) is a new diagnostic technique [92,[122][123][124][125][126]. Its diagnostic effectiveness and complication rates are varied and depend on the experience of the person performing the procedure [123,125,[127][128][129][130][131][132][133][134][135][136][137][138][139]. The mean mortality due to this diagnostic procedure only has been estimated at 0.2%, with less frequent sudden exacerbations than in the case of SLB (1.2% vs 6.1%).…”
Section: Introductionmentioning
confidence: 99%
“…The mean mortality due to this diagnostic procedure only has been estimated at 0.2%, with less frequent sudden exacerbations than in the case of SLB (1.2% vs 6.1%). However, there are frequent complications of pneumothorax (0% vs 26% with TBLC; in the case of SLB, the rates of pneumothorax or persistent air leak are lower) and bleeding (on average, 5.3% vs 0.8% with SLB) [111,123,128,133,[135][136][137][138][139][140][141][142][143][144][145].…”
Section: Introductionmentioning
confidence: 99%